Publication
Video
Supplements and Featured Publications
Glaucoma 360: Highlights from 2020Volume
Glaucoma 360: Lowering IOP using the MIMS solution
Author(s):
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma called MIMS — Minimally Invasive Micro Sclerostomy — solution, designed to create a single-patient-use sterile tool and a multi-use external machine, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Articles in this issue
Assessing the angle: Getting back to basics
OCTA: The jury is still out
Funding new technologies for glaucoma treatment
Glaucoma drug delivery devices enter new frontier
Glaucoma devices: Now and in the future
Glaucoma 360: Lowering IOP using the MIMS solution
Beating burnout with camaraderie
Status of glaucoma: diagnostics and treatments in flux
Next frontier in glaucoma: Beyond IOP-lowering treatments
Normal tension glaucoma: testing diagnostic skills
Diagnostics: Innovative ways of looking at glaucoma
Glaucoma medications: Getting down to the basics
Glaucoma devices provide impressive IOP-lowering results
Glaucoma 360: Decision-making in surgical glaucoma
Glaucoma treatment alternatives Thinking outside the box
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
